JBIO

Latest SEC Filings & News for JBIO

1 most recent filing and news item mentioning JBIO. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/JBIO/news?limit=20"

Pull JBIO filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJun 1, 2026Positive

Jade Biosciences presents JADE101 Phase 1 interim data ahead of Phase 2 trial

Jade Biosciences held a conference call on June 1, 2026 to discuss interim Phase 1 data for JADE101, a clinical-stage therapeutic candidate. The company plans to advance to Phase 2 enrollment and potentially Phase 3 registrational studies pending positive results.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.